There appears to be a paradox in the context of smoking and the risk of psoriatic arthritis (PsA), such that current smoking increases the risk of developing PsA in the general population but protects against the same risk among patients with psoriasis, according to a study.
Atacicept demonstrates efficacy in systemic lupus erythematosus (SLE), reducing disease activity and severe flare while having an acceptable safety profile, especially in patients with high disease activity and serologically active disease, according to results from the phase IIb, multicentre ADDRESS II trial.
Tocilizumab may improve skin score and forced vital capacity stabilization in patients with systemic sclerosis, while potentially increasing the risk of serious infections, according to the open-label data of the faSScinate* trial.
Patients with systemic lupus erythematosus (SLE) are prone to have cognitive impairment (CI), and the Montreal Cognitive Assessment (MoCA) appears to be a useful tool for detecting CI in SLE, according to a recent study. In addition, CI is less likely to occur in patients with more years of education.
Patients with systemic lupus erythematosus (SLE), compared to those without, have an increased risk of mortality after the first month following an ischaemic stroke, a recent study has found. In addition, functionality becomes poorer at 3 months.
Compared with injection of intra-articular steroids (IAS), cooled radiofrequency ablation (CRFA) is more effective at long-term pain management and physical function improvement for painful knee osteoarthritis (OA), a new study suggests.